An Phat Bioplastics Joint Stock Company (AAA) Fair Value & Analysis
Consumer Cyclical · VN · Market cap 2.7T VND
Fair value as of: Jun 25, 2026
Analysis
An Phat Bioplastics Joint Stock Company (AAA) currently trades at 7,410 VND, while our model-based Fair Value estimate is 19,889 VND — implying the stock looks roughly 168.4% undervalued today. We read business quality at 88/100 (high quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
An Phat Bioplastics Joint Stock Company, together with its subsidiaries, manufactures and trades plastic packaging, plastic products, and plastic resins in Vietnam, Singapore, the United States, Korea, and internationally. The company offers plastic packaging products; compostable, krafted paper, food, garbage, and shopping/fashion bags; PE liners; stretch and agriculture films; and draw tape and plastic bags, gloves, knives, forks, and straws under the AnEco brand name. It also provides additives and limestone powders; develops industrial park infrastructure; trades other plastic products; manufactures engineering and household plastics, and molds and mechanical machining products; leases factories; and manufactures construction materials and interior decoration. The company was formerly known as An Phat Plastic And Green Environment Joint Stock Company and changed its name to An Phat Bioplastics Joint Stock Company in April 2019. An Phat Bioplastics Joint Stock Company was founded…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is An Phat Bioplastics Joint Stock Company (AAA) undervalued?
What is the fair value of AAA?
What is the quality score of AAA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.